1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East & Africa Biopharmaceuticals Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East & Africa Biopharmaceuticals Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East & Africa Biopharmaceuticals Market Regional Analysis
6.2 Middle East & Africa Biopharmaceuticals Market Revenue 2020-2028 (US$ Billion)
6.3 Middle East & Africa Biopharmaceuticals Market Forecast Analysis
7. Middle East & Africa Biopharmaceuticals Market Analysis – by Product Type
7.1 Monoclonal Antibodies
- 7.1.1 Overview
- 7.1.2 Monoclonal Antibodies: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.2 Recombinant Vaccines
- 7.2.1 Overview
- 7.2.2 Recombinant Vaccines: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.3 Conventional Vaccines
- 7.3.1 Overview
- 7.3.2 Conventional Vaccines: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.4 Recombinant Growth Factors
- 7.4.1 Overview
- 7.4.2 Recombinant Growth Factors: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.5 Purified Proteins
- 7.5.1 Overview
- 7.5.2 Purified Proteins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.6 Recombinant Proteins
- 7.6.1 Overview
- 7.6.2 Recombinant Proteins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.7 Recombinant Hormones
- 7.7.1 Overview
- 7.7.2 Recombinant Hormones: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.8 Recombinant Enzymes
- 7.8.1 Overview
- 7.8.2 Recombinant Enzymes: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.9 Cell & Gene Therapies
- 7.9.1 Overview
- 7.9.2 Cell & Gene Therapies: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
7.10 Cytokines/Interferon/Interleukins
- 7.10.1 Overview
- 7.10.2 Cytokines/Interferon/Interleukins: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8. Middle East & Africa Biopharmaceuticals Market Analysis – by Application
8.1 Oncology
- 8.1.1 Overview
- 8.1.2 Oncology: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.2 Inflammatory & Infectious Disease
- 8.2.1 Overview
- 8.2.2 Inflammatory & Infectious Disease: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.3 Autoimmune Disorders
- 8.3.1 Overview
- 8.3.2 Autoimmune Disorders: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.4 Metabolic Disorders
- 8.4.1 Overview
- 8.4.2 Metabolic Disorders: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.5 Hormonal Disorders & Growth Failure
- 8.5.1 Overview
- 8.5.2 Hormonal Disorders & Growth Failure: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.6 Cardiovascular Diseases
- 8.6.1 Overview
- 8.6.2 Cardiovascular Diseases: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
8.7 Neurological Diseases
- 8.7.1 Overview
- 8.7.2 Neurological Diseases: Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast, 2020-2028 (US$ Billion)
9. Middle East & Africa Biopharmaceuticals Market – Middle East and Africa Analysis
9.1 Overview
9.2 Middle East and Africa
- 9.2.1 Middle East & Africa Biopharmaceuticals Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 9.2.1.1 Middle East & Africa Biopharmaceuticals Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 South Africa:
Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.1.1 South Africa: Middle East & Africa Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.1.2 South Africa: Middle East & Africa Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.2 Saudi Arabia:
Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.2.1 Saudi Arabia: Middle East & Africa Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.2.2 Saudi Arabia: Middle East & Africa Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.3 UAE:
Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.3.1 UAE: Middle East & Africa Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.3.2 UAE: Middle East & Africa Biopharmaceuticals Market Breakdown, by Application
- 9.2.1.4 Rest of Middle East and Africa:
Middle East & Africa Biopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Billion)
- 9.2.1.4.1 Rest of Middle East and Africa: Middle East & Africa Biopharmaceuticals Market Breakdown, by Product Type
- 9.2.1.4.2 Rest of Middle East and Africa: Middle East & Africa Biopharmaceuticals Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 AbbVie Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AGC Biologics AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Amgen Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bristol-Myers Squibb Co
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Eli Lilly and Co
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Johnson & Johnson
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Lonza Group AG
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Thermo Fisher Scientific Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Middle East & Africa Biopharmaceuticals Market
